Journal of International Oncology››2012,Vol. 39››Issue (12): 916-920.

Previous ArticlesNext Articles

Strategy of anti-angiogenesis and antiangiogenic drugs in NSCLC

ZHAO Xiang-Fei, NIE Qing, KANG Jing-Bo

  1. Department of Radio-Oncology, Navy General Hospital , Beijing 100048, China

  • Online:2012-12-08Published:2012-11-15

Abstract:Development and metastasis of NSCLC are closely related to angiogenesis. Several distinct groups of vascular – targeted therapies have evolved: anti-VEGF monoclonal antibody , Small Molecules, Vascular disrupting agents,Endothelial cell growth inhibitor,et al. Antiangiogenic treat could make longer survival than conventional treatment. The strategy of anti-angiogenic drugs combined conventional treatment is are being studied.

Key words:Carcinoma, non-small-cell lung,Angiogenesis,Molecular tergeted therapy